.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Merck
Citi
Johnson and Johnson
Mallinckrodt
Cipla
Colorcon
Fuji
Cerilliant
Daiichi Sankyo

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017601

« Back to Dashboard
NDA 017601 describes OPTIMINE, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the OPTIMINE profile page.

The generic ingredient in OPTIMINE is azatadine maleate. There are two drug master file entries for this compound. Additional details are available on the azatadine maleate profile page.

Summary for NDA: 017601

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Respiratory Tract Agents

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength1MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired Orange Book Patents for NDA: 017601

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
OPTIMINE
azatadine maleate
TABLET;ORAL017601-001Approved Prior to Jan 1, 19823,419,565► Subscribe
Schering
OPTIMINE
azatadine maleate
TABLET;ORAL017601-001Approved Prior to Jan 1, 19823,717,647► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Deloitte
Novartis
Dow
Fuji
Queensland Health
Federal Trade Commission
QuintilesIMS
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot